TCM Biotech International Corp. 4169.TWO Stock
TCM Biotech International Corp. Price Chart
TCM Biotech International Corp. 4169.TWO Financial and Trading Overview
| TCM Biotech International Corp. stock price | 52.7 TWD |
| Previous Close | 60.5 TWD |
| Open | 60.8 TWD |
| Bid | 59.4 TWD x 0 |
| Ask | 60 TWD x 0 |
| Day's Range | 58.9 - 61 TWD |
| 52 Week Range | 29.05 - 65.1 TWD |
| Volume | 111.17K TWD |
| Avg. Volume | 138.27K TWD |
| Market Cap | 2.87B TWD |
| Beta (5Y Monthly) | 0.038013 |
| PE Ratio (TTM) | 154.35898 |
| EPS (TTM) | 0.35 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | August 26, 2021 |
| 1y Target Est | N/A |
4169.TWO Valuation Measures
| Enterprise Value | 2.95B TWD |
| Trailing P/E | 154.35898 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.5704927 |
| Price/Book (mrq) | 5.3382993 |
| Enterprise Value/Revenue | 3.672 |
| Enterprise Value/EBITDA | 72.122 |
Trading Information
TCM Biotech International Corp. Stock Price History
| Beta (5Y Monthly) | 0.038013 |
| 52-Week Change | 90.61% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 65.1 TWD |
| 52 Week Low | 29.05 TWD |
| 50-Day Moving Average | 56.17 TWD |
| 200-Day Moving Average | 41.68 TWD |
4169.TWO Share Statistics
| Avg. Volume (3 month) | 138.27K TWD |
| Avg. Daily Volume (10-Days) | 100.66K TWD |
| Shares Outstanding | 47.59M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.034 |
| Trailing Annual Dividend Yield | 0.056% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1028.8:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 2.27% |
| Operating Margin (ttm) | 3.15% |
| Gross Margin | 55.89% |
| EBITDA Margin | 5.09% |
Management Effectiveness
| Return on Assets (ttm) | 1.87% |
| Return on Equity (ttm) | 3.46% |
Income Statement
| Revenue (ttm) | 802.42M TWD |
| Revenue Per Share (ttm) | 16.86 TWD |
| Quarterly Revenue Growth (yoy) | 23.59% |
| Gross Profit (ttm) | 448.49M TWD |
| EBITDA | 40.86M TWD |
| Net Income Avi to Common (ttm) | 18.27M TWD |
| Diluted EPS (ttm) | 0.39 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 89.94M TWD |
| Total Cash Per Share (mrq) | 1.89 TWD |
| Total Debt (mrq) | 157.46M TWD |
| Total Debt/Equity (mrq) | 29.34 TWD |
| Current Ratio (mrq) | 2.285 |
| Book Value Per Share (mrq) | 11.277 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 52.24M TWD |
| Levered Free Cash Flow (ttm) | 63.66M TWD |
Profile of TCM Biotech International Corp.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 11, Jihu Road |
| ZIP | 114 |
| Phone | 886 2 2697 2628 |
| Website | https://www.tcmbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for the prevention and treatment of liver diseases. The company's products include osteoarthritis treatment products, osteoporosis treatment preparations, iron preparations, antivirals preparations, urinary system treatment products, expectorants/mucolytic agents, antineoplastics agents, anti-hypertensive preparations, and anti-diabetic preparations, anti-adhesion systems, pellefeel wound care systems, Philips non-invasive ventilators, and others, as well as medical devices and functional foods. It is also developing TCM-800B for the treatment of hepatitis B; PTX-9908 for the treatment of liver cancer; and PTD-9908 for the anti-PD-1 treatment. The company sells its products in Taiwan, the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines, China, and internationally. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Q&A For TCM Biotech International Corp. Stock
What is a current 4169.TWO stock price?
TCM Biotech International Corp. 4169.TWO stock price today per share is 52.7 TWD.
How to purchase TCM Biotech International Corp. stock?
You can buy 4169.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TCM Biotech International Corp.?
The stock symbol or ticker of TCM Biotech International Corp. is 4169.TWO.
Which industry does the TCM Biotech International Corp. company belong to?
The TCM Biotech International Corp. industry is Biotechnology.
How many shares does TCM Biotech International Corp. have in circulation?
The max supply of TCM Biotech International Corp. shares is 59.05M.
What is TCM Biotech International Corp. Price to Earnings Ratio (PE Ratio)?
TCM Biotech International Corp. PE Ratio is 150.57143000 now.
What was TCM Biotech International Corp. earnings per share over the trailing 12 months (TTM)?
TCM Biotech International Corp. EPS is 0.35 TWD over the trailing 12 months.
Which sector does the TCM Biotech International Corp. company belong to?
The TCM Biotech International Corp. sector is Healthcare.